Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of DNA-Enabled Industries

Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage. Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service. Ansa is solving current industry bottlenecks associated with synthesizing complex [...]

Biognosys and NeoGenomics Expand Global Strategic Partnership Initiatives on Multiple Discovery Proteomics Solutions Supporting Biopharma R&D

Biognosys’ leading discovery proteomics services to add depth to NeoGenomics’ multiomics solutions for biopharma clinical trials and research The two companies will present scientific posters at the AACR Annual Meeting 2022 detailing the capabilities of their combined offerings ZURICH -- Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today a [...]

Finnish Organ-On-Chip startup Finnadvance raises a €1.2 million seed funding round to expand to foreign markets

Today, Finnish Organ-On-Chip startup Finnadvance announced that they’ve secured a €1.2 million seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new investor: Takoa Invest. Finnadvance is a biotechnology start-up [...]

AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC)

Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites WATERTOWN, Massachusetts – Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corporation, one of the world’s leading scientific instrumentation and life-science solutions companies. AmberGen’s innovative [...]

ENDAVA ANNOUNCES PARTNERSHIP WITH SOPHIA GENETICS

Endava is leveraging its technical capabilities to support SOPHiA GENETICS in its mission to inform the best course of action for patients and research worldwide by democratizing data-driven medicine.  SOPHiA GENETICS – a Swiss  healthtech company listed on Nasdaq – have engaged Endava to support them in various IT projects across software engineering, technology operations and [...]

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

London, UK — PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit, a lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive high-throughput detection of RNA sequences. The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable [...]

Axol Bioscience raises £3.2 million GBP (c. $4.2 million USD)

Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, [...]

PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System

Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass. --  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated technology with high-throughput capability to [...]

ERS Genomis and CIEA Japan Sign Cas9 License Agreement

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a license agreement with Central Institute for Experimental Animals (“CIEA”) in Japan. This is a non-exclusive licensing agreement granting CIEA access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 [...]

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Adobe and Intel marketing leader, Marta DeBellis, joins as Chief Marketing Officer Rapid7 go-to-market growth strategist, Stephanie Furfaro, appointed as Chief Revenue Officer San Diego, CA — Insightful Science, the global leader in R&D scientific software that connects science, data, and decision-making, today announced the appointments of Marta DeBellis as Chief Marketing Officer (CMO), and Stephanie Furfaro as [...]

Access IBO on Knowledge Center